European molecular diagnostics companies

Last UpdatedMarch 5, 2024

by

Shape and size of the market. In the previous year, the share was 10. The European molecular diagnostics market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Deal background: • Roche acquires GenMark, a provider of multiplex Zeesan Biotech is a biomedical company specialized in the development ZeptoMetrix provides products and services for clinical diagnostics. S. DNA/RNA Synthesis. 180729 - Fiscal Code and number of registration to Vercelli Companies Register no 13144290155 PROGRAM OF THE EUROPEAN MEETING ON MOLECULAR DIAGNOSTICS 2024 Grand Hotel Huis ter Duin, Noordwijk aan Zee October 09 – 11, 2024 Wednesday October 09, 2024 08. Abbott Laboratories, Hologic Corporation, Danaher Corporation , Agilent Technologies and F Hoffmann-la Roche Ltd are the major companies operating in this market. Feb 28, 2024 · Bruker to acquire ELITechGroup revenues of ~Euro 150 million p. 4 billion, and it is estimated to reach the mark of USD 7. 2 billion by 2027. Hoffmann-La Roche, commonly called Roche, is a healthcare company that develops, manufactures, and markets a wide range of healthcare solutions. a. In 2021, Siemens Healthineers was the largest company worldwide based on revenue from diagnostics which stood at almost 19 billion U. Cerca Biotech is the European subsidiary of Shuwen Biotech, a highly reputable and innovative molecular and point of care diagnostics organisation. These meetings are a continuation of the former Benelux- and European meetings on PCR diagnostics. 35 – 12. Feb 8, 2017 · As with drug development and biotech tools, the molecular diagnostics market has its major players—companies that include Roche, QIAGEN, Hologic, Grifols, Abbott Laboratories, Siemens Healthcare, Becton Dickinson (BD), Beckman Coulter, and bioMérieux. Methodology. , Abbott Laboratories develops, manufactures, and markets a diverse range of healthcare products. ” Jun 10, 2022 · The Markets and Markets In Vitro Diagnostics Crystal Ball Event was a global virtual event that took place on February 28, 2022. We offer a comprehensive variety of instrument platforms, an expanding menu of optimized assays, and analysis and reporting software Miguel Giralt, CEO, Diagnostica Longwood. The EMMD is organised every two years in the Netherlands. About the 2024 meeting. 8B to boost its molecular diagnostics portfolio and to expand the global reach of GenMark’s products. with >80% consumables revenue. The rising awareness of personalized medicine among the masses, the escalating prevalence of chronic diseases such as cancer, cardiovascular disorders, and infectious diseases, and the emerging trend toward point-of-care testing . Infectious disease diagnostics accounted for around 32 percent of the total IVD market in Germany in 2020. 60 billion by 2032, exhibiting a CAGR of 6. Molecular diagnostics is a collection of techniques used to analyze biological markers in the genome and proteome, and how their cells express their genes as proteins, applying molecular biology to medical testing. Real-time PCR kit for the detection and quantification of Herpes Simplex types 1 & 2. 1% from 2021 to 2028. Whether you need molecular reagents, antibodies, or other products for in vitro diagnostic testing, you can find them at Meridian. To be responsive, laboratories need to have flexible solutions and options to suit their individual needs. 50 million. Diagnostic Revenue: $0. Roche was the second-largest medical diagnostics May 9, 2019 · 8-9 May 2019. 30 Opening EMMD 2024 (Main Lecture Hall) 10. Our analysts selected these companies for a variety of reasons. --(BUSINESS WIRE)-- Hologic, Inc. Specialist using "QIAsymphony", an automation platform for molecular diagnostic tests. g. Mar 1, 2021 · MARLBOROUGH, Mass. Stay informed and navigate efficientlyNew York Apr 5, 2018 · The change will be felt most immediately in Europe, where the Dutch molecular diagnostics company recently secured a CE-IVD mark for its next-generation sequencing-based MammaPrint BluePrint Breast Cancer Recurrence and Molecular Subtyping Kit. We leverage patented mathematical methods and algorithmic enhancements to enrich signal processing from the most The Veterinary Diagnostics Market is expected to reach USD 7. While the disease remains uncontained, such demand is likely to keep growing. 2 billion industry, according to a report by Markets and Markets Research in 2022, and is poised to steadily grow by 5. dollars. 6 billion industry by 2017 (Kalorama) and surpass $8 billion by 2020 (Grand View Research), the field is seeing growing interest from both Metabiomics is an early stage molecular diagnostics company that is developing in-vitro diagnostics, screening tests, and health assays that leverage breakthroughs in next-generation DNA sequencing, computational systems biology, and human microbiome sciences. A highly diverse team, our multidisciplinary interests and expertise span the field of molecular biology, nanomaterials science and device engineering. 57%. The global market for personalized medicine has grown rapidly since the inception of the Precision Medicine Initiative, announced by Barack Obama during his 2015 State of the Union address. The first diagnostic COVID-19 test was developed by researchers in Germany in mid-January 2020, 2 and the first Dec 22, 2021 · The European molecular diagnostics market was valued at USD 3,435 million in 2020, and it is expected to reach USD 7,790 million in 2026, registering a CAGR of 8. Founded in 2015, Creative Biosciences (Chinese: 康立明生物) is a molecular diagnostic company dedicated to making breakthroughs in early diagnosis, early intervention, and prognosis monitoring of chronicle diseases specifically in cancer. B. Hoffmann-La Roche (Switzerland) Founded in 1896 and headquartered in Basel, Switzerland, F. Make an appointment. Dec 29, 2023 · In 2024, a select group of clinical and lab diagnostic companies stands out as trailblazers, harnessing advanced technologies to redefine precision, speed, and accuracy in diagnostics. World-class service for physicians and patients. VIEW THE m2000. 2. 55 billion by 2029. Generally speaking in vitro diagnostics (IVD) tests are considered medical devices. Kumar, a Physician-Scientist turned technocrat, The Europe molecular diagnostics market size is projected to exhibit a growth rate (CAGR) of 5. Hoffmann-La Roche Ltd. 32 billion by 2029. com | USD 3,500. Get better answers Get better answers. The innovative field of the healthcare sector has become more and more crucial during the world crisis caused by the pandemic. Technologies and platforms are being optimized for speed and reliability in a variety of settings, including bedside, resource-limited and pharmacy testing. 92 billion in 2023 and is expected to grow from USD 73. Total Employees: ~ 66,000. Through the deal, Hologic will pay $159 million, subject to Oct 31, 2018 · With a growing repository of personalized data at the molecular level, molecular-diagnostics companies are uniquely positioned to unlock value. Our team at PharmaShots has compiled a list of the top 20 diagnostics companies based on their 2020 diagnostics revenue. 58B Total Employees: ~2,000. Founded Year: 1847 . The size of global sepsis diagnostics market in terms of revenue was estimated to be worth $634 million in 2024 and is poised to reach $890 million by 2029, growing at a CAGR of 7. 0 billion in 2017 and is expected to witness 7. Furthermore, EMQN’s highly qualified peer group of assessors take pride in their Oct 31, 2022 · Roche purchases multiplex molecular diagnostics company GenMark. 4% in the next four years – to a predicted market value of $30. With more than 25 years of molecular experience, BIOFIRE sets the standard for molecular diagnostics through its pioneering advances in syndromic infectious disease testing. F. To address such widespread and rapid development, the molecular diagnostics market requires distributors that are May 27, 2024 · The global in-vitro diagnostics (IVD) market size was USD 74. The region holds a significant share of the global molecular diagnostics market and is expected to register a robust CAGR during 2022-2030. 45 billion in 2024 and grow at a CAGR of 8. 6% during 2024-2032. All our solutions are already on track to be IVDR Jun 9, 2023 · Here are the top 10 companies operating in the Molecular Diagnostics Market. 79 billion in the next few years, witnessing a CAGR of 8. Exact Sciences’ products, services, mission, and people all work together to support early cancer detection and smarter treatment decisions. 94 billion in 2024 and grow at a CAGR of 9. The global molecular diagnostics market size was valued at 43. Mar 22, 2022 | Published by: VPGMarketResearch. The Europe in vitro diagnostics market (IVD) was valued at $13,825 million in 2019, and is projected to reach $18,647 million at a CAGR of 4. The market for point-of-care diagnostics is projected to surpass $38 billion by 2022, and rapid testing is changing the paradigm for clinical care across many disease areas. While a good portion of the market is attributed to reagents and polymerase chain reaction tests Mar 1, 2021 · - Transaction Expands and Diversifies Hologic’s Diagnostic Business Across Test Menu, Customer Segments and Geography – Hologic, Inc. Founded: 2003 Agendia is a molecular diagnostics company that develops genomic tests for breast cancer. 3%. This guarantees the best possible molecular diagnostic procedure, analytical performance, and clinical interpretation. Molecular Diagnostics is used in a variety of settings, including hospitals, laboratories, and Jan 5, 2024 · Here are the top 10 companies operating in the In-vitro Diagnostics Market. 00 Company sponsored satellite symposium 10. Companies working with PCR also work in 39 other areas: COVID-19 (29) DNA Sequencing (14) Molecular Diagnostics (14) Diagnostics (13) Reagents (11) EUA (9) Point-of-Care Diagnostics (8) Bioinformatics (4) Sep 2, 2021 · Agendia. Find out why Cepheid's solutions are a top choice for fast, accurate, and easy diagnostic testing. Deal activity Cepheid's GeneXpert® System is the world's most flexible platform, providing healthcare professionals with a best in class test menu for any setting — from the core lab to near patient applications. We participated in the largest prospective studies to date in Jan 11, 2024 · Here are the Top 10 Companies Operating in the Point-of-care Diagnostics Market. Dr. Headquartered in Hamburg-Altona, Germany, altona Diagnostics is privately owned and employs more than 300 people worldwide. altona Diagnostics is a medical diagnostic company that develops and manufactures in-vitro diagnostic tests for the DNA based detection of pathogens such as viruses, bacteria or parasites. Hologic today announced that it acquired molecular diagnostic company Diagenode for $159 million. 3,500+. 99 billion in 2024 to USD 117. 00 Session 1: Molecular diagnostics. 30 Registration & coffee 10. 09 Billion in 2023, growing at a CAGR of 7. Yet significant activity in molecular diagnostics has come in recent years from smaller Mar 1, 2021 · Hologic Acquires European Molecular Diagnostic Company Diagenode for Approximately $159 Million-- Transaction Expands and Diversifies Hologic’s Diagnostic Business Across Test Menu, Customer Jun 2, 2023. 19 Bn by the end of 2028. Varizymes creates and sells custom solutions for molecular biology research. We offer technical support and training on all our products and are committed to increasing the efficiency of laboratory testing and enhancing patient care. Dec 24, 2021 · The European molecular diagnostics market was valued at USD 3,435 million in 2020, and it is expected to reach USD 7,790 million in 2026, registering a CAGR of 8. 57% during the forecast period. Abbott Laboratories (U. It is estimated to expand at a CAGR of 11. Top Health Diagnostics Companies Zava Zava is an online medical service provider 2,250+. In 2020, the European molecular diagnostics sector was valued at USD 3. Inquire Before Buying. convenient locations across the United States. To date, the group has launched 5 diagnostics tests, 7 different laboratory workflows, and developed a broad range of IP. 0% during the forecast period (2024-2032). 57% to reach USD 12. Europe Molecular Diagnostics Market size was valued at USD 2. Molecular diagnostics can be used to diagnose various Jan 16, 2024 · Explore Molecular Diagnostics Market trends by application, product type, and technology. E. (Switzerland) Founded in 1896 and headquartered in Basel, Switzerland. 2 billion from only 8 transactions in 2020. 8 billion U. 8 billion. In-Vitro Diagnostics (IVD) are medical devices that perform diagnostic tests on biological samples such as blood Jun 3, 2024 · Natera advances molecular diagnostics with integrity and scientific rigor, and supports integration of information provided by our tests into health care decision making. altona Diagnostics GmbH, Amoy Diagnostics Co Oct 25, 2023 · Notably, key companies including Siemens Healthineers and Roche Diagnostics, both based in Germany, are renowned for their state-of-the-art diagnostic solutions. The core product, Colosafe, can precisely detect and interpret the mutated Jun 10, 2021 · The companies are in the race to develop fast- accurate methods for detecting patients infected with the SARS-CoV-2 virus. 8% from 2020 to 2027. In Europe and the United States alone, molecular-diagnostic demand rose 20-fold between March and October 2020 (Exhibit 1). Founded in 1994, as one of China’s earliest developed enterprises Zyagen develops, manufactures, and sells life science products, biochemical, and m 2000 REALTI M E SYSTEM AND ASSAYS. 3 Our work. 09B. Market Cap: ~$66. Diagnostic Revenue: $18. 3. Find a location. This approach allows the detection of diseases and their causative agents with high accuracy and sensitivity, even prior to manifestation of symptoms. The global market was valued at US$ 14. Furthermore, these instruments are employed in Germany Infectious Disease Molecular Diagnostics Market: Supplier Sales and Shares, Volume and Sales Segment Forecasts for 100 Virology, Bacteriology, Parasitology and Mycology Tests, Competitive Analysis, Emerging Technologies, Latest Instrumentation, Growth Opportunities. Deal announced: 15 March 2021. In Mar 2021, Roche acquired GenMark Diagnostics for $1. Meridian Bioscience is a global leader in providing life science materials and diagnostic solutions. TORINO, Italy, February 28, 2024 -- ( BUSINESS WIRE )-- Bruker Corporation (Nasdaq: BRKR) announced May 11, 2022 · INEX Innovate is Asia's first molecular diagnostics company for women. A. 1. In 2021, Siemens Healthineers was the largest company based on diagnostics revenue at 18. The report sheds light on the current situation Apr 3, 2024 · NEW YORK, April 3, 2024 /PRNewswire/ -- The global molecular diagnostics market size is estimated to grow by USD 7722. The Asia-Pacific Molecular Diagnostics Market is projected to reach $11. Ranging from clinical chemistry analyzers to molecular diagnostics, these solutions are extensively utilized within the country and exported globally. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights Feb 20, 2024 · favorite_border. a They may be reagents, techniques, instruments, or a combination of these used in vitro for the examination of specimens such as blood, urine or tissue with the goal of obtaining a diagnosis from assays in a controlled environment outside a living organism. 89 billion in 2020 and is projected to register a substantial CAGR during the forecast period, 2021–2028. Moreover, point-of-care solutions are used in sports medicine examinations, in pharmacies, and even on cruise ships. Professional point-of-care testing (POCT) is a collective term for the performance of patient-oriented tests in primary healthcare settings and hospitals. The region has a robust infrastructure for R&D, which has led to the rapid adoption of innovative diagnostic techniques and platforms. monitoring. Molecular Diagnostics. The product detects and identifies melanoma (skin cancer) patients that have a low risk for nodal metastasis and therefore can safely stay alive without a sentinel lymph node biopsy (SLNB Dec 11, 2020 · As COVID-19 has spread, the demand for molecular testing, regarded as the gold standard for diag­nosing infectious disease, has exploded. Deal value: $1. Molecular system with a comprehensive infectious disease assay menu along with LDT capability and primary tube utilization delivers operational efficiency, reliability and confidence in results. The market is estimated to Jul 11, 2023 · A revolution: The impact of COVID-19 on in vitro diagnostic testing. Nov 7, 2023 · Redding, California - November 7, 2023 Europe Molecular Diagnostics Market to be Worth $13. 81B. ChromaCode is a molecular diagnostics company with a bioinformatics focus and pedigree from Illumina, Google[x], Luminex, and Caltech. 5% growth from 2018 to 2024. Operating across six continents, we harness digital data to enable precision diagnostics and improve health outcomes. Molecular diagnostics research is focused on genomic and proteomic analysis with the goal of identifying disease biomarkers, creating better diagnostic assays and ultimately finding new Mar 1, 2021 · March 1, 2021 By Danielle Kirsh. 257 R. lab tests available to help you find answers. 50% vs 2020. Molecular diagnostics help detect the targeted genetic material in human, viral, and bacterial genomes. Clinomics Europe is a Budapest-based company, established in 2021 June as the first EU subsidiary of Clinomics Inc, Korea. Clinical laboratories offering molecular diagnostic tests face ever-changing requirements and demands. 99 Mn in 2020. --(BUSINESS WIRE)--Hologic, Inc. Sentinel Diagnostics was chosen to be on the cover of the Magazine MD Tech Review for the Special “In Vitro Diagnostics”, Europe Edition. With a common vision of addressing real-world unmet biomedical challenges, we Feb 15, 2023 · Creative Biosciences. Molecular Biology. The Netherlands headquartered biotech company has launched two tests: one to predict the likelihood of breast cancer recurring after surgery and another to classify the type of tumor a patient has. 96% to reach USD 5. As bioMérieux’s Global Center of Excellence for Molecular Diagnostics, no other company has FDA-cleared and CE-IVD marked assays for more pathogens. Stock Exchange: ETR Companies working with Molecular Diagnostics also work in 100 other areas: Apply. According to WHO by 2020, the European population should increase Mar 2, 2021 · MARLBOROUGH, Mass. 2. Services. V. Data sourced from Crunchbase and SEMRush. Molecular Diagnostics can also be used to monitor the effectiveness of treatments. Europe, Asia Pacific, and the Middle East and Africa. Molecular diagnostic tests are increasingly used in many This article showcases some of the most popular players in the Health Diagnostics space. Growing geriatric population that prefers personalized medicines will drive the market growth during the upcoming years. Jan 16, 2024 · A recent analysis report on the Molecular Diagnostics Market by Persistence Market Research indicates that the global sales for 2022 reached US$ 38 Billion. With an experienced team and innovative products, TRUPCR Europe supplies high quality qPCR molecular diagnostic products throughout Europe. The intergovernmental organisation, headquartered in Heidelberg, was founded in 1974 with the mission of promoting molecular biology research in Europe, training young scientists, and May 4, 2015 · With molecular diagnostics projected to grow to a $7. This list may include both state and private ventures providing the most value within the Health Diagnostics industry. 17 Billion by 2030 from US$ 17. , a privately held, European developer and manufacturer of molecular diagnostic assays and epigenetics products, for approximately $159 million (130 million euros), subject to working capital and other customary closing adjustments. During the forecast period, the Asia Pacific market is projected to experience the highest CAGR of 13. Another driver of the dynamic development of infectious disease diagnostics is molecular HPV testing, which has been part of the early detection of cervical carcinoma since January 2020. (Nasdaq: HOLX), a global leader in women's health, announced today that it has acquired Diagenode, a privately held, European developer and manufacturer of molecular diagnostic assays and epigenetics products, for approximately $159 million (130 million euros), subject to working capital and other customary closing adjustments. Newswise — ROCKVILLE, Md. Analysts’ Viewpoint on Global Market Scenario. Find your test. Unit 6, Williams House, Lloyd Street. Xcelris Genomics. 21% during the forecast period, 2019-2028. Siemens Healthineers was the best performing segment of the wider altona Diagnostics. 87 billion by 2030, at a CAGR of 7. The growth of the market is attributed to the growing elderly population, technological advancements, and rising external funding for R&D. Jun 9, 2022 · Roche’s 2021 revenue boosted to 26. Throughout the pandemic, Europe saw massive investment in IVD testing to scale up capacity, as well as an urgency to innovate quickly to cope with historic demand. Description: Xcelris is India's leading genomics research organization offering cutting edge May 9, 2024 · The Molecular Diagnostics Market 2024 report provides a detailed analysis of the dynamic of the market with extensive focus on secondary research. From molecular diagnostics to next-gen imaging, these 15 companies are at the forefront of ushering in a new era in healthcare. 2% from 2023 to 2030. With 29 member states, laboratories at six locations across Europe and thousands of scientists and engineers working together, the European Molecular Biology Laboratory is a powerhouse of biological expertise. Business Area (s): Genomics. Genetics and genomics are gradually marking out the new outlines of tomorrow‘s clinical diagnostics and our laboratories are investing Introduction: The merging of molecular diagnostics with personalized medicine has led to a surge in development of molecular-based companion diagnostics. Share Capital €55. (Nasdaq: HOLX), a global leader in women's health, announced today that it has acquired Diagenode, Inc. Explore our innovative solutions and trusted partnerships that redefine the possibilities of life from discovery to diagnosis. – Feb. Key questions relate to regulatory responsibility, and to challenges for validation, including CE-marking requirements for CDx used in medicines clinical trials. Top Molecular Diagnostics Solution Companies in Europe - Healthcare Tech Outlook present the list of Top Molecular Diagnostics Solution Companies in Europe are the leading provider of molecular-diagnostics-europe technology solutions and services. ) Incorporated in 1888 and headquartered in Illinois, U. Description Table of Content Download Free PDF Sample. Our tests are clinically validated in over 200 peer-reviewed publications with over 3 million patients studied. 00 – 10. Also, North America has several major molecular diagnostics companies in the molecular diagnostics sector. The company operates through four reportable business segments: Established The Europe molecular point of care diagnostics market is predicted to project growth at a CAGR of 15. We are honored to be in the “Top 10 In Vitro Diagnostic Solution Companies in Europe – 2021”. Molecular diagnostics are utilized by the field of medicine to diagnose and monitor diseases at the molecular level. Shuwen and Cerca are passionate about healthcare and are working to create world-leading innovations Jan 19, 2017 · The Company aims to be a leading supplier of reagents and instrumentation in Southern Africa, through partnerships with prestigious manufacturers e. Ravi Kumar. Anticipated to exhibit a Compound In September 2022, SkylineDx, a prominent molecular diagnostics company, announced the launch of Merlin Assay as CE-IVD distributable test kit in Europe. 20, 2024 – The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today released the Europe Molecular Diagnostics Market, By Products (Reagents & Kits, Instruments and Services & Softwares), Technology (Mass Spectrometry (MS), Capillary Electrophoresis, Next Generation Sequencing (NGS), Chips and Microarray, Polymerase Chain Reaction (PCR)-Based Methods, Cytogenetics, In Situ Hybridization (ISH or FISH), Molecular Imaging and Others), Application (Oncology, Pharmacogenomics XCyton is a revolutionary Molecular Biology Company founded in 1993 by Dr. May 9, 2019 · Companion diagnostics (CDx) are not expressly regulated in current EU medicines or medical devices legislation, creating uncertainty for both pharmaceutical and diagnostics companies. 71 mn from 2023 to 2027, according to Technavio. It is used to identify genetic mutations, diagnose infectious diseases, and detect cancer. 948. Idexx Laboratories, Zoetis, Inc, Thermo Fisher Scientific Inc, Biomérieux SA and Virbac Corporation are the major companies operating in this market. In vitro diagnostics (IVD) include medical devices, assays and reagents, which are employed in diagnosis of a medical condition. 4% To develop effective rapid diagnostics, developer News Today's news Our research group focuses on creating innovative technologies to empower molecular diagnostics and patient care. COVID-19 (82) EUA (39) Diagnostics (20) Cancer Diagnostics (18) Infectious Disease (18) Feb 21, 2022 · In 2021, molecular diagnostics companies agreed to 24 mergers and acquisitions, which had an aggregate deal value of $9 billion versus $13. HSV1, HSV2, VZV R-GENE ®. This is the 13th European Meeting on Molecular Diagnostics (EMMD), devoted to all aspects of molecular diagnostics in human disease and pathology. Hoffmann-La Roche Ltd is a research-based healthcare company majorly engaged in creating innovative medicines and providing solutions for diagnostics. May 11, 2024 · Eurofins clinical diagnostics laboratories offer testing services in all medical specialties, from routine testing to esoteric testing including advanced and often proprietary genetic testing solutions. Companion diagnostics, defined as 'a medical device, often an in vitro device, which provides information that is essential for the safe and effective use of a corresponding drug or biological product', are key to the appropriate utilization Molecular Diagnostics is the application of molecular biology techniques to study human diseases, including infectious disease, inherited conditions and cancer. The global molecular diagnostics industry is expected to reach the value of US$ 37. Our Diagnostics businesses are industry leaders that improve diagnostic confidence around the world—from local clinics and family physicians’ offices to top trauma, cancer, and critical care centers. The factors favoring the growth of the market are the significant efforts put forth by major countries of the region to enhance the adoption of precision medicine solutions, and the growing demands for Molecular Diagnostics is a type of medical testing that uses molecular biology techniques to detect and diagnose diseases. Kumar PBS Pabbisetty, Associate Director, IQVIA MedTech, was among the four expert panelists that delved into discussions about the most promising opportunities in the IVD ecosystem, emerging technologies and approaches, and the key factors and considerations About Us. Over the years, the company has developed a broad menu of solutions including more than 45 CE-IVD assays, instruments and software, guaranteeing superior workflows design and enhanced performances. Jun 15, 2023 · The molecular diagnostics sector is a $23. tests performed each year for patients of all ages. Feb 28, 2024 · The ELITech esoteric molecular diagnostics portfolio is nicely complementary to our MALDI Biotyper ® microbial identification platform in infectious disease diagnostics, and both together establish Bruker as an innovative and growing ’Tier 2’ infectious disease specialist in the in-vitro diagnostics (IVD) market. 0% from 2024 to 2029. , F. (Nasdaq: HOLX), a global leader in women's health, announced today that it has acquired Diagenode, a privately held, European developer and manufacturer of molecular diagnostic assays and epigenetics products, for approximately $159 million (130 million The Europe Molecular Diagnostics Market is expected to reach USD 3. To help companies navigate through the best-of-breed in vitro diagnostic solution providers, @MD Tech ELITechGroup Spa is the company’s European Molecular Diagnostics entity, based in Turin, Italy. 30 - 10. Exact Sciences Laboratories are dedicated to delivering the most accurate test results to support informed decision making. Even though elective procedures have been postponed indefinitely Companies working with Cancer Diagnostics also work in 79 other areas: Liquid Biopsy (28) Molecular Diagnostics (18) COVID-19 (13) Personalized Medicine (11) Artificial Intelligence (10) Diagnostics (8) DNA Sequencing (8) Cancer Therapeutics (7) EMQN provides quality assurance tools and knowledge to the human genomic testing community through External Quality Assessment (EQA) schemes. 25 Billion by 2030 Europe Molecular Diagnostics Market by Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology), End User (Hospital, Diagnostic Lab) - Forecast to 2030 Molecular Diagnostics. As a leading diagnostics company, we know how high-quality laboratory Feb 21, 2024 · Molecular Diagnostics Market size will reach US$ 28. nh qy pl at no qi wh we op ae